Federated Hermes’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-145,000
Closed -$14.8M 2349
2019
Q2
$14.8M Sell
145,000
-1,281,700
-90% -$138M 0.04% 442
2019
Q1
$162M Hold
1,426,700
0.4% 44
2018
Q4
$55.8M Buy
1,426,700
+165,300
+13% +$7.17M 0.15% 138
2018
Q3
$68.8M Sell
1,261,400
-262,702
-17% -$18M 0.16% 144
2018
Q2
$126M Buy
1,524,102
+26,314
+2% +$2.03M 0.37% 58
2018
Q1
$99.7M Sell
1,497,788
-353,612
-19% -$20.4M 0.29% 71
2017
Q4
$95.2M Buy
1,851,400
+263,063
+17% +$18.9M 0.27% 72
2017
Q3
$142M Buy
1,588,337
+224,699
+16% +$17.1M 0.41% 49
2017
Q2
$81.5M Buy
1,363,638
+438
+0% +$24.5K 0.23% 81
2017
Q1
$72.7M Sell
1,363,200
-8,000
-0.6% -$475K 0.21% 89
2016
Q4
$68.4M Sell
1,371,200
-262,700
-16% -$14.1M 0.21% 97
2016
Q3
$98.1M Sell
1,633,900
-13,700
-0.8% -$790K 0.28% 61
2016
Q2
$84.2M Buy
1,647,600
+503,606
+44% +$21.5M 0.25% 74
2016
Q1
$33.8M Buy
1,143,994
+200,984
+21% +$6.34M 0.1% 167
2015
Q4
$42.7M Buy
943,010
+281,610
+43% +$14.8M 0.14% 148
2015
Q3
$27.6M Buy
661,400
+293,200
+80% +$15.3M 0.09% 229
2015
Q2
$22.2M Buy
368,200
+260,700
+243% +$17.2M 0.07% 295
2015
Q1
$8.33M Buy
+107,500
New +$6.19M 0.03% 497

Other funds holding ONCE

Federated Hermes's ONCE Position: Q3 2019 in Review

Federated Hermes sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 145,000 shares — an estimated $14.8M sold.

Federated Hermes first reported a position in ONCE in Q1 2015 and held it in 18 quarters. The position peaked at $162M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Federated Hermes reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Federated Hermes sold 145,000 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $14.8M.
  • Federated Hermes first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 18 quarters.
  • Federated Hermes's Spark Therapeutics, Inc. Common Stock position peaked at $162M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.